Version 4 · Coming Soon

PREDICT v4 is on its way.

We are building a new and more powerful version of PREDICT — the online tool that helps patients and clinicians see how different treatments for early invasive breast cancer might improve survival rates.

PREDICT v4 will draw on expanded data from a large, diverse, contemporary US population; updated treatment evidence and guidelines; and improved modelling, including incorporation of Oncotype DX scores, to provide clearer and more personalized estimates.

In the meantime, please continue to use PREDICT v3.

Get notified when v4 launches:

One email when v4 launches. No spam, ever.

Did you mean to visit Predict Prostate?

Expanded US population data

Trained on a large, diverse, contemporary US patient cohort to reflect real-world breast cancer outcomes across the population.

Updated treatment evidence

Reflects current treatment guidelines and evidence, including chemotherapy, targeted therapies, and immunotherapy, so clinicians can counsel patients more fully.

Improved personalised estimates

Enhanced modelling, including incorporation of Oncotype DX scores, delivers clearer, more personalised survival estimates for each patient.

University of Cambridge – Winton Centre for Risk and Evidence Communication